Q1 2020 Brainstorm Cell Therapeutics Inc Earnings Call Transcript
Good day and welcome to the Brainstorm Cell Therapeutics first-quarter 2020 conference call. At this time, all participants are in a listen-only mode. As a reminder, this call is recorded.
And I would now like to introduce your host for today's conference, Mr. Sean Leous from ICR Westwicke. Mr. Leous, you may begin.
Thank you for joining the Brainstorm Cell Therapeutics call.
Before we begin, the opening remarks. We would like to remind listeners that this conference call contains numerous statements, descriptions, forecasts, and projections regarding Brainstorm Cell Therapeutics, NASDAQ: BCLI, and its potential future business operations and performance, statements regarding the market potential for the treatment of neurodegenerative disorders such as ALS and MS, the sufficiency of our existing capital resources for continuing operations in 2020 and beyond, the safety and clinical effectiveness of our NurOwn technology platform, our clinical trials of NurOwn and related clinical development programs and our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |